These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21323894)

  • 21. Old dogs and new tricks in antimicrobial discovery.
    Butler MS; Blaskovich MA; Owen JG; Cooper MA
    Curr Opin Microbiol; 2016 Oct; 33():25-34. PubMed ID: 27262526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver enhances antibiotic activity against gram-negative bacteria.
    Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
    Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of Global Antibiotic Resistance.
    Morehead MS; Scarbrough C
    Prim Care; 2018 Sep; 45(3):467-484. PubMed ID: 30115335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The rise of resistant gram-negative bacteria].
    Kuijper EJ; van Dissel JT
    Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combating evolution with intelligent design: the neoglycoside ACHN-490.
    Armstrong ES; Miller GH
    Curr Opin Microbiol; 2010 Oct; 13(5):565-73. PubMed ID: 20932796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
    Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
    Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.
    Rice LB
    Mayo Clin Proc; 2012 Feb; 87(2):198-208. PubMed ID: 22305032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research and development of antibiotics: insights from patents and citation network.
    Zhang M; Kong X; Zheng J; Wan JB; Wang Y; Hu Y; Shao R
    Expert Opin Ther Pat; 2016 May; 26(5):617-27. PubMed ID: 26986226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.
    Strich JR; Warner S; Lai YL; Demirkale CY; Powers JH; Danner RL; Kadri SS
    Lancet Infect Dis; 2020 Oct; 20(10):1172-1181. PubMed ID: 32505231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India.
    Alam M; Imran M
    Recent Pat Antiinfect Drug Discov; 2018; 13(2):164-179. PubMed ID: 29984669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the antibiotic resistance crisis.
    Rossolini GM; Arena F; Pecile P; Pollini S
    Curr Opin Pharmacol; 2014 Oct; 18():56-60. PubMed ID: 25254623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
    Chopra I; Schofield C; Everett M; O'Neill A; Miller K; Wilcox M; Frère JM; Dawson M; Czaplewski L; Urleb U; Courvalin P
    Lancet Infect Dis; 2008 Feb; 8(2):133-9. PubMed ID: 18222164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
    Falagas ME; Mavroudis AD; Vardakas KZ
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):747-63. PubMed ID: 27400643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New aminoglycoside antibiotics.
    Dozzo P; Moser HE
    Expert Opin Ther Pat; 2010 Oct; 20(10):1321-41. PubMed ID: 20670208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.